brca cell lines bt474 (DSMZ)

DSMZ is a verified supplier

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

DSMZ brca cell lines bt474

SH3-domain containing GRB2-like 1 ( SH3GL1 ) is generally highly expressed in breast cancer (BRCA) and is closely related to a variety of immune cells. (A) Hematoxylin and eosin (H&E) staining diagram of BRCA and immunohistochemistry (IHC) staining diagram of breast markers, including pan-cytokeratin, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2). (B) Western blot analysis of the protein expression levels of SH3GL1 in tissues of BRCA and adjacent normal tissue (Adj). ∗∗∗ P < 0.001, in comparison with Adj. (C) Reverse transcription quantitative polymerase chain reaction (RT-qPCR) to detect the mRNA expression level of SH3GL1 in BRCA and Adj in clinical samples, ∗∗∗ P < 0.001, in comparison with Adj. (D) Flow cytometry for the proportion of natural killer (NK) cells, T cells, B cells, regulatory T cells (Treg), M0, M1, dendritic cell (DC) and mast cell in the tissues of BRCA and Adj, ∗∗∗ P < 0.001, in comparison with Adj. (E) RT-qPCR to detect the expression level of SH3GL1 in commonly used BRCA cell lines. Among them, MCF-10A was normal breast epithelial cell, <t>BT474:</t> three Yang; SKBR3: HER2 high expression; MCF-7: ER + ; MDA-MB-453: ER-HER2 + ; MDA-MB-231: Three Yin. ∗ indicates comparison with MCF-10A. ∗∗ P < 0.01, ∗∗∗ P < 0.001. (F, G) Western blot analysis of the protein expression level of SH3GL1 in commonly used BRCA cell lines. In comparison with MCF-10A, ∗ P < 0.01, ∗∗ P < 0.01, ∗∗∗ P < 0.001. The expression values for different cell types were not ordered according to any specific rank. M0/M1: macrophage subtypes. TNBC: triple-negative breast cancer; GAPDH: glyceraldehyde-3-phosphate dehydrogenase. BCRA-1 and BCRA-2 represent breast cancer samples obtained from two independent patients.

Brca Cell Lines Bt474, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 98 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bt474+cells/BT-474/pmc12861226-176-4-67
Average 95 stars, based on 98 article reviews

brca cell lines bt474 - by Bioz Stars, 2026-10

95/100 stars

Images

1) Product Images from "Targeting SH3GL1 for prognosis and immune response in breast cancer"

Article Title: Targeting SH3GL1 for prognosis and immune response in breast cancer

Journal: Journal of Pharmaceutical Analysis

doi: 10.1016/j.jpha.2025.101377

Figure Legend Snippet: SH3-domain containing GRB2-like 1 ( SH3GL1 ) is generally highly expressed in breast cancer (BRCA) and is closely related to a variety of immune cells. (A) Hematoxylin and eosin (H&E) staining diagram of BRCA and immunohistochemistry (IHC) staining diagram of breast markers, including pan-cytokeratin, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2). (B) Western blot analysis of the protein expression levels of SH3GL1 in tissues of BRCA and adjacent normal tissue (Adj). ∗∗∗ P < 0.001, in comparison with Adj. (C) Reverse transcription quantitative polymerase chain reaction (RT-qPCR) to detect the mRNA expression level of SH3GL1 in BRCA and Adj in clinical samples, ∗∗∗ P < 0.001, in comparison with Adj. (D) Flow cytometry for the proportion of natural killer (NK) cells, T cells, B cells, regulatory T cells (Treg), M0, M1, dendritic cell (DC) and mast cell in the tissues of BRCA and Adj, ∗∗∗ P < 0.001, in comparison with Adj. (E) RT-qPCR to detect the expression level of SH3GL1 in commonly used BRCA cell lines. Among them, MCF-10A was normal breast epithelial cell, BT474: three Yang; SKBR3: HER2 high expression; MCF-7: ER + ; MDA-MB-453: ER-HER2 + ; MDA-MB-231: Three Yin. ∗ indicates comparison with MCF-10A. ∗∗ P < 0.01, ∗∗∗ P < 0.001. (F, G) Western blot analysis of the protein expression level of SH3GL1 in commonly used BRCA cell lines. In comparison with MCF-10A, ∗ P < 0.01, ∗∗ P < 0.01, ∗∗∗ P < 0.001. The expression values for different cell types were not ordered according to any specific rank. M0/M1: macrophage subtypes. TNBC: triple-negative breast cancer; GAPDH: glyceraldehyde-3-phosphate dehydrogenase. BCRA-1 and BCRA-2 represent breast cancer samples obtained from two independent patients.

Techniques Used: Staining, Immunohistochemistry, Western Blot, Expressing, Comparison, Reverse Transcription, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Flow Cytometry

SH3-domain containing GRB2-like 1 ( SH3GL1 ) in breast cancer (BRCA) epithelial cells promotes their interaction with immune cells. (A) The mRNA expression level of SH3GL1 in normal organoids (Normal-Orgs) and BRCA organoids (BRCA-Orgs) was detected by reverse transcription quantitative polymerase chain reaction (RT-qPCR). ∗∗ P < 0.01, in comparison with Normal-Orgs. (B) Western blot analysis of SH3GL1 protein expression in Normal-Orgs and BRCA-Orgs. ∗∗ P < 0.01, in comparison with Normal-Orgs. (C) RT-qPCR to detect the mRNA expression level of SH3GL1 in BRCA-Orgs and BT474 before and after co-culture. (D) Western blot analysis of SH3GL1 protein levels in BRCA-Orgs and BT474 before and after co-culture. (E) RT-qPCR to detect mRNA expression of tumor susceptibility marker CD44 in BRCA-Orgs and BT474 before and after co-culture. (F) Representative pictures of proliferating marker Ki67 in BRCA-Orgs before and after co-culture detected by IHC. (G) Statistics of the maximum passage times of BRCA-Orgs before and after co-culture. (H) Statistics on the number of BRCA-Orgs formed from single cells to organoids before and after co-culture. (I) Representative pictures of 5-ethynyl-2′-deoxyuridine (EdU) staining of BT474 cells before and after co-culture. The right side is the relative statistical map of EdU positive cells. (J) Representative images of scratch migration experiment of BT474 cells before and after co-culture. Statistical map of relative scratch closure area on the right. (K) RT-qPCR to detect the mRNA expression of SH3GL1 before and after co-culture of BRCA-Orgs and MDA-MB-231 after knockdown of SH3GL1 . (L,M) Western blot analysis of SH3GL1 protein expression in BRCA-Orgs and MDA-MB-231 cells before and after co-culture after SH3GL1 knockdown (L), and the statistical chart (M). (N) Representative pictures of proliferation marker Ki67 before and after co-culture detected by IHC after BCRA-Orgs SH3GL1 knockdown, and statistical graph. (O) Representative pictures of EdU staining of MDA-MB-231 cells before and after co-culture after SH3GL1 knockdown (red is EdU positive cells), and the relative statistical map of EdU positive cells. (P) Representative images of scratch migration experiment of MDA-MB-231 cells before and after co-culture after SH3GL1 knockdown, and statistical map of relative scratch closure area. In the D–P plots, ∗∗ P < 0.01, ∗∗∗ P < 0.001. (Q) Representative picture of transwell migration induced PBMC (T cells) to BRCA-Orgs, Where fluorescence represents T cells, and statistical graph on the right. In the Q plot, ∗∗∗ P < 0.001, in comparison with Normal-Orgs or shNC. IHC: immunohistochemistry; CD44: tumor susceptibility marker; transwell: migration assay system; PBMC: peripheral blood mononuclear cells.

Figure Legend Snippet: SH3-domain containing GRB2-like 1 ( SH3GL1 ) in breast cancer (BRCA) epithelial cells promotes their interaction with immune cells. (A) The mRNA expression level of SH3GL1 in normal organoids (Normal-Orgs) and BRCA organoids (BRCA-Orgs) was detected by reverse transcription quantitative polymerase chain reaction (RT-qPCR). ∗∗ P < 0.01, in comparison with Normal-Orgs. (B) Western blot analysis of SH3GL1 protein expression in Normal-Orgs and BRCA-Orgs. ∗∗ P < 0.01, in comparison with Normal-Orgs. (C) RT-qPCR to detect the mRNA expression level of SH3GL1 in BRCA-Orgs and BT474 before and after co-culture. (D) Western blot analysis of SH3GL1 protein levels in BRCA-Orgs and BT474 before and after co-culture. (E) RT-qPCR to detect mRNA expression of tumor susceptibility marker CD44 in BRCA-Orgs and BT474 before and after co-culture. (F) Representative pictures of proliferating marker Ki67 in BRCA-Orgs before and after co-culture detected by IHC. (G) Statistics of the maximum passage times of BRCA-Orgs before and after co-culture. (H) Statistics on the number of BRCA-Orgs formed from single cells to organoids before and after co-culture. (I) Representative pictures of 5-ethynyl-2′-deoxyuridine (EdU) staining of BT474 cells before and after co-culture. The right side is the relative statistical map of EdU positive cells. (J) Representative images of scratch migration experiment of BT474 cells before and after co-culture. Statistical map of relative scratch closure area on the right. (K) RT-qPCR to detect the mRNA expression of SH3GL1 before and after co-culture of BRCA-Orgs and MDA-MB-231 after knockdown of SH3GL1 . (L,M) Western blot analysis of SH3GL1 protein expression in BRCA-Orgs and MDA-MB-231 cells before and after co-culture after SH3GL1 knockdown (L), and the statistical chart (M). (N) Representative pictures of proliferation marker Ki67 before and after co-culture detected by IHC after BCRA-Orgs SH3GL1 knockdown, and statistical graph. (O) Representative pictures of EdU staining of MDA-MB-231 cells before and after co-culture after SH3GL1 knockdown (red is EdU positive cells), and the relative statistical map of EdU positive cells. (P) Representative images of scratch migration experiment of MDA-MB-231 cells before and after co-culture after SH3GL1 knockdown, and statistical map of relative scratch closure area. In the D–P plots, ∗∗ P < 0.01, ∗∗∗ P < 0.001. (Q) Representative picture of transwell migration induced PBMC (T cells) to BRCA-Orgs, Where fluorescence represents T cells, and statistical graph on the right. In the Q plot, ∗∗∗ P < 0.001, in comparison with Normal-Orgs or shNC. IHC: immunohistochemistry; CD44: tumor susceptibility marker; transwell: migration assay system; PBMC: peripheral blood mononuclear cells.

Techniques Used: Expressing, Reverse Transcription, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Comparison, Western Blot, Co-Culture Assay, Marker, Staining, Migration, Knockdown, Fluorescence, Immunohistochemistry, Transwell Migration Assay

other:

Article Title: Tissue Architectural Cues Drive Organ Targeting of Tumor Cells in Zebrafish
Article Snippet: For all experiments, larvae were transferred to fish water supplemented with N-phenylthiourea (PTU; Cat. No. P7629–25G, Millipore Sigma, St. Louis, MO) between 18–22 hours post-fertilization to inhibit melanin formation and maintain optical transparency.

Article Title: Antibody-immune agonist conjugate and applications thereof
Article Snippet: MS: Thermo Fisher Q Exactive Plus, Water2795-Quattro micro triple quadrupole mass spectrometer HPLC: Waters 2695, Agilent 1100, Agilent 1200 Semi-preparative HPLC: Lisure HP plus 50D Flow Cytometry: CytoFLEX S HIC-HPLC: Butyl-HIC; mobile phase A: 25 mM PB, 2M (NH4)2SO4, pH 7.0; mobile phase B: 25 mM PB, pH 7.0; flow rate: 0.8 ml/min; acquisition time: 25 min; injection amount: 20 μg; column temperature: 25° C.; detection wavelength: 280 nm; sample chamber temperature: 8° C. SEC-HPLC: column: TSK-gel G3000 SWXL, TOSOH 7.8 mm ID×300 mm, 5 μm; mobile phase: 0.2 M KH2PO4, 0.25 M KCl, pH 6.2; flow rate: 0.5 ml/min; acquisition time: 30 min; injection volume: 50 μl; column temperature: 25° C.; detection wavelength; 280 nm; sample tray temperature: 8° C. CHO was obtained from Thermo Fisher Scientific; pcDNA 3.3 was obtained from Life Technology; HEK293F was obtained from Prejin; PEIMAX transfection reagent was obtained from Polyscience; MabSelect Sure ProA was obtained from GE; Capto S ImpAct was obtained from GE; Rink-amide-MBNA-resin and dichloro resin were obtained from Nankai synthesis; HCC1954 was obtained from ATCC CAT #CRL-2338; SK-BR-3 was obtained from ATCC CAT #HTB-30; BT474 cells was obtained from ATCC CAT #HTB-20; JIMT1 cells was obtained from DSMZ CAT #ACC589; Colo205 cells was obtained from ATCC CAT #CRL-222; NCI-N87—Claudin 18.2 human gastric cancer cells was obtained from KYinno Biotechnology Co., Ltd; Claudin 18.2-negative NCI-N87 parental cells was obtained from ATCC CAT #CRL-5822; MC38hHER2 murine colorectal cancer cells was obtained from Biocytogen; NUGC4 human gastric cancer cells was obtained from JCRB CAT #JCRB0834; NCI-N87 cells (ATCC CAT #CRL-5822); MDA-MB-468 was obtained from ATCC CAT #HTB-132.

Article Title: Antibody-immune agonist conjugate and applications thereof
Article Snippet: MS: Thermo Fisher Q Exactive Plus, Water2795-Quattro micro triple quadrupole mass spectrometer HPLC: Waters 2695, Agilent 1100, Agilent 1200 Semi-preparative HPLC: Lisure HP plus 50D Flow Cytometry: CytoFLEX S HIC-HPLC: Butyl-HIC; mobile phase A: 25 mM PB, 2M (NH4)2SO4, pH 7.0; mobile phase B: 25 mM PB, pH 7.0; flow rate: 0.8 ml/min; acquisition time: 25 min; injection amount: 20 μg; column temperature: 25° C.; detection wavelength: 280 nm; sample chamber temperature: 8° C. SEC-HPLC: column: TSK-gel G3000 SWXL, TOSOH 7.8 mm ID×300 mm, 5 μm; mobile phase: 0.2 M KH2PO4, 0.25 M KCl, pH 6.2; flow rate: 0.5 ml/min; acquisition time: 30 min; injection volume: 50 μl; column temperature: 25° C.; detection wavelength; 280 nm; sample tray temperature: 8° C. CHO was obtained from Thermo Fisher Scientific; pcDNA 3.3 was obtained from Life Technology; HEK293F was obtained from Prejin; PEIMAX transfection reagent was obtained from Polyscience; MabSelect Sure ProA was obtained from GE; Capto S ImpAct was obtained from GE; Rink-amide-MBHA-resin and dichloro resin were obtained from Nankai synthesis; HCC1954 was obtained from ATCC CAT #CRL-2338; SK-BR-3 was obtained from ATCC CAT #HTB-30; BT474 cells was obtained from ATCC CAT #HTB-20; JIMT1 cells was obtained from DSMZ CAT #ACC589; Colo205 cells was obtained from ATCC CAT #CRL-222; NCI-N87-Claudin 18.2 human gastric cancer cells was obtained from KYinno Biotechnology Co., Ltd; Claudin 18.2-negative NCI-N87 parental cells was obtained from ATCC CAT #CRL-5822; MC38hHER2 murine colorectal cancer cells was obtained from Biocytogen; NUGC4 human gastric cancer cells was obtained from JCRB CAT #JCRB0834; NCI-N87 cells (ATCC CAT #CRL-5822); MDA-MB-468 was obtained from ATCC CAT #HTB-132.

Multiple Displacement Amplification:

Article Title: Tissue Architectural Cues Drive Organ Targeting of Tumor Cells in Zebrafish
Article Snippet: .. The MDA-MB-231 and Bt474 cell line derivatives had EV≥0.86 compared to parental MDA-MB-231 or Bt474 cells, respectively, and did not match the STR profiles for any other cells in the DSMZ profile database (EV≤0.83) using the DSMZ online STR matching analysis tool ( Dirks et al., 2010 ). .. For all experiments, larvae were transferred to fish water supplemented with N-phenylthiourea (PTU; Cat. No. P7629–25G, Millipore Sigma, St. Louis, MO) between 18–22 hours post-fertilization to inhibit melanin formation and maintain optical transparency.

Cell Culture:

Article Title: Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer.
Article Snippet: .. SKBR3 and BT474 cells were from the American Type Culture Collection (ATCC), and JIMT-1 cells [33] were purchased from the German Collection of Microorganisms and Cell Culture (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ)). ..

Review